Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Moreadith Randall, Chief Scientific Officer. Officer active across 1 company, notably Serina Therapeutics, Inc.. Aggregated, 35 reports have been published. History available since 30 June 2025. The latest transaction was disclosed on 23 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Moreadith Randall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4,326 shares@ US$0.060.0009% mcap3.5% of flowCommon StockSEC:0001301120-25-000007:0
25 of 35 declarations
About Moreadith Randall
Moreadith Randall is Chief Scientific Officer at Serina Therapeutics, Inc. She has 35 filings in total, and for the most recent sampled filings held, the period runs from 2025-07-02 to 2026-03-24, with the transaction pattern shown as option exercise and buy and sell amounts both at 0.